Open original FDA record ↗Recall record
- FDA identifier
- Z-0434-2022
- Company in FDA record
- bioMerieux, Inc.
- FDA record creation date
- Dec 28, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.
Source facts
- Action
- For products with No remaining shelf life (taking into account the revised expiration date): - Identify impacted lots - Stop using the listed impacted lots - Destroy the remaining impacted lots in your inventory For products with remaining shelf life (taking into account the revised expiration date): - Identify impacted products and lots listed - Update product expiration date per your internal procedures of the remaining usable lots to meet the new revised expiration date specified in Table 1 - Continue product use until the revised expiration date. Consignees are asked to distribute this information to all appropriate personnel in their laboratory, retain a copy in their files, and forward this information to all parties that may use this product, including others to whom you may have transferred affected product. Complete the Acknowledgement Form in Attachment A and return it to USFieldActions@biomerieux.com or Fax to: (919) 620-3306 to confirm receipt of this notice.
- Initiated
- 2021-09-22
- Root cause
- Nonconforming Material/Component
- Distribution
- US Nationwide distribution.
- Recall number
- Z-0434-2022
- Recall status
- Open, Classified
- CDRH record ID
- 190199
- FDA record created
- 2021-12-28
- Recall event number
- 88797